DateContentStatus
24/05/2024 Page: Support for industry on clinical data publicationUpdated
24/05/2024 Page: Industry annual bilateral meetingsUpdated
23/05/2024 Page: SME Regulation and reportsUpdated
23/05/2024 Herbal: Rhodiolae roseae rhizoma et radix - herbal medicinal productUpdated
22/05/2024 Page: Website outages and upgradesUpdated
17/05/2024 Page: Outcomes of imposed non-interventional post-authorisation safety studiesUpdated
16/05/2024 Page: Network PortfolioUpdated
14/05/2024 Page: Clinical Trials Information System: training and supportUpdated
08/05/2024 Page: CVMP recommendations on limited market classification and eligibility for authorisation under Article 23Updated
07/05/2024 Page: Need for maximum residue limit (MRL) evaluation for biological substances - Scientific guidelineUpdated
07/05/2024 Herbal: Hippocastani cortex - herbal medicinal productUpdated
07/05/2024 Page: PRIME: priority medicinesUpdated
07/05/2024 Page: COVID-19 vaccines: key factsUpdated
06/05/2024 Page: ProcurementUpdated
03/05/2024 Page: ICH M10 on bioanalytical method validation - Scientific guidelineUpdated
03/05/2024 Page: Plasma master file certificatesUpdated
03/05/2024 Page: Big dataUpdated
03/05/2024 Page: Real-world evidenceNew
03/05/2024 Page: Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guidelineNew
02/05/2024 Page: Information ManagementUpdated
02/05/2024 Herbal: Malvae sylvestris flos - herbal medicinal productUpdated
02/05/2024 Herbal: Malvae folium - herbal medicinal productUpdated
02/05/2024 Page: Handling competing interestsUpdated
02/05/2024 Page: Quality of medicines questions and answers: Part 1Updated
02/05/2024 Page: Stability testing for applications for variations to a marketing authorisation for veterinary medicinal products - Scientific guidelineUpdated